CLINICAL TRIAL IN INDIA: RISE AND FALL

  • Chitral Kulshreshtha Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.
  • M P Venkatesh Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.
  • K Shrisha Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.
  • Pramod T.M. Kumar Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.
  • Pramod T.M. Kumar Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.
DOI https://doi.org/10.22270/ijdra.v3i1.11

Abstract

Fight with the disease is the ever evolving frontier for human beings. Discovery of new drugs and devices through
clinical research are the armory to help in the fight with the affliction of mankind. Clinical trials, test potential
treatments in human volunteers to see whether they should be approved for wider use in the general population. A
treatment could be a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy. India stood
as a global hub for clinical trials in past years. Later, the amendments made in Indian regulations paved for the decline
of clinical trials. The aim of this article is to provide the details about the Indian clinical trial application filing
process, the amendments made in its regulations and the challenges faced by Indian clinical trial industry.
 

Keywords: Clinical trial, India, Schedule Y, Good Clinical Practice.

Downloads

Download data is not yet available.

Author Biographies

Chitral Kulshreshtha, Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics,
JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

M P Venkatesh, Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics,
JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

K Shrisha, Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics,
JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pramod T.M. Kumar, Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics,
JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pramod T.M. Kumar, Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics,
JSS College of Pharmacy, JSS University, S.S Nagar, Mysuru – 570015, Karnataka, India.

References

1. Schedule Y. [Internet]. New Delhi; Jan 2005
[cited 2013 Dec 18]. Available from:
http://dbtbiosafety.nic.in/act/schedule_y.pdf
2. NIH, Why Are Clinical Trials Important?
[Internet]. US; Sept 2014 [cited 2013 Dec 21].
Available from:
http://www.nhlbi.nih.gov/health/health-topics
/topics /clinicaltrials/ important.html
3. Policy and Medicine, The Importance of Clinical
Trials 2013 [Internet]. US; Sept 2014 [cited 2013
Dec 21]. Available from:
http://www.policymed.com/2010/05/theimportance-of-clinical-trials.html
4. FDA, Conducting Clinical Trials [Internet]. US;
Sept 2014 [updated 2014 Feb 9; cited 2013 Dec
19]. Available from:
http://www.fda.gov/drugs/developmentapproval
process/conductingclinicaltrials/default.htm
5. Bhatt Arun. Ethics at crossroads: Global
guidelines vs. local laws Perspectives in Clinical
Research. 2013 Jan; 4(1): 1-3.
6. Pacific bridge medical Clinical Trials for
Pharmaceuticals/Drugs and Medical Devices in
Asia [Internet]. [cited 2013 Dec 20]. Available
from:
http://www.pacificbridgemedical.com/regulatory
-services/clinical
7. Ministry of Health Family Welfare [Internet].
MHRA;2013 [cited 2013 Dec 24].
Available from:
http://mohfw.nic.in/index1.php?linkid=338&lev
el=1&lid=1640&lang=1
8. CDSCO, India, Schedule Y Drugs & cosmetics
Act 1940 [Internet]. CDSCO;2013 Sept [cited
2013 Dec 21]. Available from:
http://cdsco.nic.in/SC%20Order%2030th%20Se
pt%202013.pdf
9. Clinicaltrials.gov, Trends, Charts, and Maps
[Internet]. US NIH [updated 2015 Jan; cited
2013 Dec 20]. Available from:
http://clinicaltrials.gov/ct2/resources/trends
10. CDSCO [Internet]. CDSCO; Official Gazette
vide notification No. F. 28-10/45-H(I) [updated
2005 Jan; cited 2013 Dec 21]. Available from:
http://cdsco.nic.in/html/schedule-y%20(
amended %20version-2005)%20original .htm
11. Indian Society for Clinical Research, Drug
Development [Internet]. ISCR; 2011 [cited
2013 Dec 21]. Available from:
http://www.iscr.org/iscr-drug-development.aspx
12. Jayasheel BG. Recent Changes in Regulations
Related to Clinical Trials Approval in India.
Pharma Times. 2012;44(05):45.
13. Shankar R. Health ministry sets up apex panel
for supervising trials on new chemical entities
[Internet]. Pharmabiz; 2013 Feb [cited 2013
Dec 22]. Available from:
http://www.pharmabiz.com/NewsDetails.aspx?
aid=73687&sid=1
14. Checklist. CDSCO [Internet]. CDSCO, New
Delhi[cited 2013 Dec 23]. Available from:
http://www.cdsco.nic.in/573(E).pdf
15. Applications for Global Clinical Trial, 2013
[Internet]. CDSCO, New Delhi[cited 2013 Dec
22]. Available from:
http://cdsco.nic.in/writereaddata/Checklist%20o
f%20New%20Drugs.pdf.
Statistics
376 Views | 1335 Downloads
How to Cite
Kulshreshtha, C., M. P. Venkatesh, K. Shrisha, P. T. Kumar, and P. T. Kumar. “CLINICAL TRIAL IN INDIA: RISE AND FALL”. International Journal of Drug Regulatory Affairs, Vol. 3, no. 1, Mar. 2015, pp. 1-13, doi:10.22270/ijdra.v3i1.11.
Issue
Vol 3 No 1 (2015): VOLUME 3, ISSUE 1, 2015
Section
Review

The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.

I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.

Download link for COPYRIGHT FORM